Screener

Eligibility screening

HA-1 T TCR T Cell Immunotherapy for Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Sponsored by Fred Hutchinson Cancer CenterStudy detailsClinicalTrials.gov

1 US site in WA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.